U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8 - K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 1, 2000
BSD MEDICAL CORPORATION
Commission file number 0-10783
DELAWARE 75-1590407
(State of Incorporation) (IRS Employer Identification Number)
2188 West 2200 South
Salt Lake City, Utah 84119
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (801) 972-5555
CURRENT EVENTS ON FORM 8-K
ITEM 5. OTHER EVENTS
BSD Medical Corporation has entered into an agreement with
de Jong & Associates as its investor relations representative.
The newly appointed IR firm will begin services on behalf of
BSD Medical on July 1, 2000.
The initial contract with de Jong runs for twelve months,
and the firm must qualify for the incentives attached to the
agreement by June 30, 2001. The agreement contains a stock
incentive package issued as a warrant, divided into three
portions of 25,000 shares. The IR firm may purchase shares
for $3.00 each based on BSD stock appreciating to $5.00,
$7.00 and $9.00 per share respectively, as calculated on a
ten business day average.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits:
The following exhibit (numbered in accordance with Item
601 of Regulation S-B) is filed as part of this report.
Exhibit
Number Description
----------- -------------
10 Consulting Agreement between de Jong & Associates
and BSD Medical Corporation, dated July 1, 2000.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned thereunto duly
authorized.
BSD MEDICAL CORPORATION
Date: July 19, 2000 By: \s\ Hyrum A. Mead
Hyrum A. Mead
President
